OMEROS CORP Operating Income
OMEROS CORP (OMER) reported Operating Income of $74.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-12
- OMEROS CORP operating income (loss) for the quarter ending 2026-06-30 was $74.00K.
- OMEROS CORP operating income (loss) for the quarter ending 2026-03-31 was -$17.42M.
- OMEROS CORP operating income (loss) for the quarter ending 2025-12-31 was -$29.08M.
- OMEROS CORP operating income (loss) for the quarter ending 2025-09-30 was -$26.39M.
- OMEROS CORP operating income (loss) for fiscal 2025 was -$122.80M.
- OMEROS CORP operating income (loss) for fiscal 2024 was -$166.95M.
- OMEROS CORP operating income (loss) for fiscal 2023 was -$164.53M.
- OMEROS CORP operating income (loss) for fiscal 2022 was -$163.39M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed | Operating Income (Loss) 204 month | Operating Income (Loss) 207 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $74.00K 10-Q · filed 2026-08-12 | -$17.35M 10-Q · filed 2026-08-12 | -$46.43M derived: sum of 3 quarters · filed 2026-08-12 | -$72.82M derived: sum of 4 quarters · filed 2026-08-12 | ||||||
| 2026-03-31 | -$17.42M 10-Q · filed 2026-05-13 | -$46.50M derived: sum of 2 quarters · filed 2026-05-13 | -$72.89M derived: sum of 3 quarters · filed 2026-05-13 | -$105.25M derived: sum of 4 quarters · filed 2026-08-12 | ||||||
| 2025-12-31 | -$29.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$55.47M derived: sum of 2 quarters · filed 2026-03-31 | -$87.83M derived: sum of 3 quarters · filed 2026-08-12 | -$122.80M 10-K · filed 2026-03-31 | ||||||
| 2025-09-30 | -$26.39M 10-Q · filed 2025-11-13 | -$58.75M derived: sum of 2 quarters · filed 2026-08-12 | -$93.72M 10-Q · filed 2025-11-13 | -$127.07M derived: sum of 4 quarters · filed 2026-08-12 | ||||||
| 2025-06-30 | -$32.35M 10-Q · filed 2026-08-12 | -$67.32M 10-Q · filed 2026-08-12 | -$100.68M derived: sum of 3 quarters · filed 2026-08-12 | -$136.09M derived: sum of 4 quarters · filed 2026-08-12 | ||||||
| 2025-03-31 | -$34.97M 10-Q · filed 2026-05-13 | -$68.32M derived: sum of 2 quarters · filed 2026-05-13 | -$103.73M derived: sum of 3 quarters · filed 2026-05-13 | -$162.89M derived: sum of 4 quarters · filed 2026-05-13 | ||||||
| 2024-12-31 | -$33.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$68.76M derived: sum of 2 quarters · filed 2026-03-31 | -$127.92M derived: sum of 3 quarters · filed 2026-03-31 | -$166.95M 10-K · filed 2026-03-31 | -$169.26M 10-K · filed 2025-03-31 | |||||
| 2024-09-30 | -$35.41M 10-Q · filed 2025-11-13 | -$94.56M derived: sum of 2 quarters · filed 2025-11-13 | -$133.60M 10-Q · filed 2025-11-13 | -$173.36M derived: sum of 4 quarters · filed 2026-03-31 | ||||||
| 2024-06-30 | -$59.16M 10-Q · filed 2025-08-14 | -$98.19M 10-Q · filed 2025-08-14 | -$137.96M derived: sum of 3 quarters · filed 2026-03-31 | -$186.11M derived: sum of 4 quarters · filed 2026-03-31 | ||||||
| 2024-03-31 | -$39.03M 10-Q · filed 2025-05-15 | -$78.80M derived: sum of 2 quarters · filed 2026-03-31 | -$126.95M derived: sum of 3 quarters · filed 2026-03-31 | -$167.85M derived: sum of 4 quarters · filed 2026-03-31 | ||||||
| 2023-12-31 | -$39.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$87.92M derived: sum of 2 quarters · filed 2026-03-31 | -$128.82M derived: sum of 3 quarters · filed 2026-03-31 | -$164.53M 10-K · filed 2026-03-31 | ||||||
| 2023-09-30 | -$48.15M 10-Q · filed 2024-11-13 | -$89.05M derived: sum of 2 quarters · filed 2024-11-13 | -$124.77M 10-Q · filed 2024-11-13 | -$164.90M derived: sum of 4 quarters · filed 2025-03-31 | ||||||
| 2023-06-30 | -$40.90M 10-Q · filed 2024-08-07 | -$76.61M 10-Q · filed 2024-08-07 | -$116.75M derived: sum of 3 quarters · filed 2025-03-31 | -$167.52M derived: sum of 4 quarters · filed 2025-03-31 | ||||||
| 2023-03-31 | -$35.71M 10-Q · filed 2024-05-15 | -$75.85M derived: sum of 2 quarters · filed 2025-03-31 | -$126.62M derived: sum of 3 quarters · filed 2025-03-31 | -$164.06M derived: sum of 4 quarters · filed 2025-03-31 | ||||||
| 2022-12-31 | -$40.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$90.90M derived: sum of 2 quarters · filed 2025-03-31 | -$128.34M derived: sum of 3 quarters · filed 2025-03-31 | -$163.39M 10-K · filed 2025-03-31 | ||||||
| 2022-09-30 | -$50.77M 10-Q · filed 2023-11-09 | -$88.20M derived: sum of 2 quarters · filed 2023-11-09 | -$123.25M 10-Q · filed 2023-11-09 | -$166.14M derived: sum of 4 quarters · filed 2024-04-01 | ||||||
| 2022-06-30 | -$37.44M 10-Q · filed 2023-08-09 | -$72.48M 10-Q · filed 2023-08-09 | -$115.37M derived: sum of 3 quarters · filed 2024-04-01 | -$155.20M derived: sum of 4 quarters · filed 2024-04-01 | ||||||
| 2022-03-31 | -$35.05M 10-Q · filed 2023-05-09 | -$77.94M derived: sum of 2 quarters · filed 2024-04-01 | -$117.76M derived: sum of 3 quarters · filed 2024-04-01 | -$163.37M derived: sum of 4 quarters · filed 2024-04-01 | ||||||
| 2021-12-31 | -$42.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$82.72M derived: sum of 2 quarters · filed 2024-04-01 | -$128.33M derived: sum of 3 quarters · filed 2024-04-01 | -$173.62M 10-K · filed 2024-04-01 | ||||||
| 2021-09-30 | -$39.83M 10-Q · filed 2022-11-09 | -$18.25M 10-Q · filed 2021-11-09 | -$85.44M derived: sum of 2 quarters · filed 2022-11-09 | -$130.73M 10-Q · filed 2022-11-09 | -$72.88M 10-Q · filed 2021-11-09 | -$164.54M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$45.61M 10-Q · filed 2022-08-09 | -$24.02M 10-Q · filed 2021-08-09 | -$90.90M 10-Q · filed 2022-08-09 | -$54.63M 10-Q · filed 2021-08-09 | -$124.72M derived: sum of 3 quarters · filed 2022-08-09 | -$150.14M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$45.29M 10-Q · filed 2022-05-10 | -$30.61M 10-Q · filed 2021-05-10 | -$79.11M derived: sum of 2 quarters · filed 2022-05-10 | -$104.53M derived: sum of 3 quarters · filed 2022-05-10 | -$132.21M derived: sum of 4 quarters · filed 2022-05-10 | |||||
| 2020-12-31 | -$33.82M 10-K · filed 2021-03-01 | -$59.24M derived: sum of 2 quarters · filed 2021-11-09 | -$86.92M derived: sum of 3 quarters · filed 2021-11-09 | -$156.92M 10-K · filed 2023-03-13 | -$110.60M 10-K · filed 2021-03-01 | |||||
| 2020-09-30 | -$25.43M 10-Q · filed 2021-11-09 | -$53.11M derived: sum of 2 quarters · filed 2021-11-09 | -$76.78M 10-Q · filed 2021-11-09 | -$100.49M derived: sum of 4 quarters · filed 2021-11-09 | ||||||
| 2020-06-30 | -$27.68M 10-Q · filed 2021-08-09 | -$51.36M 10-Q · filed 2021-08-09 | -$75.06M derived: sum of 3 quarters · filed 2021-08-09 | -$86.16M derived: sum of 4 quarters · filed 2021-08-09 | ||||||
| 2020-03-31 | -$23.68M 10-Q · filed 2021-05-10 | -$47.38M derived: sum of 2 quarters · filed 2021-05-10 | -$58.48M derived: sum of 3 quarters · filed 2021-05-10 | -$67.82M derived: sum of 4 quarters · filed 2021-05-10 | ||||||
| 2019-12-31 | -$23.70M 10-K · filed 2021-03-01 | -$34.80M derived: sum of 2 quarters · filed 2021-03-01 | -$44.14M derived: sum of 3 quarters · filed 2021-03-01 | -$146.04M 10-K · filed 2022-03-01 | -$63.38M 10-K · filed 2020-03-02 | |||||
| 2019-09-30 | -$11.10M 10-K · filed 2021-03-01 | -$20.44M derived: sum of 2 quarters · filed 2021-03-01 | -$39.68M 10-Q · filed 2020-11-09 | -$58.15M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2019-06-30 | -$9.34M 10-K · filed 2021-03-01 | -$28.58M 10-Q · filed 2020-08-10 | -$47.05M derived: sum of 3 quarters · filed 2021-03-01 | -$82.49M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2019-03-31 | -$19.24M 10-K · filed 2021-03-01 | -$37.71M derived: sum of 2 quarters · filed 2021-03-01 | -$73.16M derived: sum of 3 quarters · filed 2021-03-01 | -$103.77M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2018-12-31 | -$18.47M 10-K · filed 2020-03-02 | -$53.92M derived: sum of 2 quarters · filed 2020-03-02 | -$84.53M derived: sum of 3 quarters · filed 2020-03-02 | -$112.22M 10-K · filed 2021-03-01 | ||||||
| 2018-09-30 | -$35.44M 10-K · filed 2020-03-02 | -$66.06M derived: sum of 2 quarters · filed 2020-03-02 | -$93.75M 10-Q · filed 2019-11-12 | -$107.87M derived: sum of 4 quarters · filed 2020-03-02 | ||||||
| 2018-06-30 | -$30.62M 10-K · filed 2020-03-02 | -$58.30M 10-Q · filed 2019-08-08 | -$72.43M derived: sum of 3 quarters · filed 2020-03-02 | -$77.54M derived: sum of 4 quarters · filed 2020-03-02 | ||||||
| 2018-03-31 | -$27.69M 10-K · filed 2020-03-02 | -$41.81M derived: sum of 2 quarters · filed 2020-03-02 | -$46.92M derived: sum of 3 quarters · filed 2020-03-02 | -$58.86M derived: sum of 4 quarters · filed 2020-03-02 | ||||||
| 2017-12-31 | -$14.12M 10-K · filed 2019-03-01 | -$19.23M derived: sum of 2 quarters · filed 2019-03-01 | -$31.17M derived: sum of 3 quarters · filed 2019-03-01 | -$43.90M 10-K · filed 2020-03-02 | ||||||
| 2017-09-30 | -$5.11M 10-K · filed 2019-03-01 | -$17.05M derived: sum of 2 quarters · filed 2019-03-01 | -$29.77M 10-Q · filed 2018-11-08 | -$41.63M derived: sum of 4 quarters · filed 2019-03-01 | ||||||
| 2017-06-30 | -$11.94M 10-K · filed 2019-03-01 | -$24.66M 10-Q · filed 2018-08-09 | -$36.52M derived: sum of 3 quarters · filed 2019-03-01 | -$48.56M derived: sum of 4 quarters · filed 2019-03-01 | ||||||
| 2017-03-31 | -$12.72M 10-K · filed 2019-03-01 | -$24.58M derived: sum of 2 quarters · filed 2019-03-01 | -$36.62M derived: sum of 3 quarters · filed 2019-03-01 | -$47.55M derived: sum of 4 quarters · filed 2019-03-01 | ||||||
| 2016-12-31 | -$11.86M 10-K · filed 2018-03-01 | -$23.89M derived: sum of 2 quarters · filed 2018-03-01 | -$34.82M derived: sum of 3 quarters · filed 2018-03-01 | -$54.28M 10-K · filed 2019-03-01 | ||||||
| 2016-09-30 | -$12.04M 10-K · filed 2018-03-01 | -$22.97M derived: sum of 2 quarters · filed 2018-03-01 | -$42.42M 10-Q · filed 2017-11-09 | -$60.46M derived: sum of 4 quarters · filed 2018-03-01 | ||||||
| 2016-06-30 | -$10.93M 10-K · filed 2018-03-01 | -$30.38M 10-Q · filed 2017-08-08 | -$48.42M derived: sum of 3 quarters · filed 2018-03-01 | -$67.72M derived: sum of 4 quarters · filed 2018-03-01 | ||||||
| 2016-03-31 | -$19.45M 10-K · filed 2018-03-01 | -$37.49M derived: sum of 2 quarters · filed 2018-03-01 | -$56.79M derived: sum of 3 quarters · filed 2018-03-01 | -$72.76M derived: sum of 4 quarters · filed 2018-03-01 | ||||||
| 2015-12-31 | -$18.04M 10-K · filed 2017-03-16 | -$37.34M derived: sum of 2 quarters · filed 2017-03-16 | -$53.31M derived: sum of 3 quarters · filed 2017-03-16 | -$71.24M 10-K · filed 2018-03-01 | ||||||
| 2015-09-30 | -$19.30M 10-K · filed 2017-03-16 | -$35.27M derived: sum of 2 quarters · filed 2017-03-16 | -$53.20M 10-Q · filed 2016-11-09 | -$73.17M derived: sum of 4 quarters · filed 2017-03-16 | ||||||
| 2015-06-30 | -$15.97M 10-K · filed 2017-03-16 | -$33.90M 10-Q · filed 2016-08-09 | -$53.87M derived: sum of 3 quarters · filed 2017-03-16 | -$71.00M derived: sum of 4 quarters · filed 2017-03-16 | ||||||
| 2015-03-31 | -$17.93M 10-K · filed 2017-03-16 | -$37.91M derived: sum of 2 quarters · filed 2017-03-16 | -$55.04M derived: sum of 3 quarters · filed 2017-03-16 | -$72.25M derived: sum of 4 quarters · filed 2017-03-16 | ||||||
| 2014-12-31 | -$19.98M 10-K · filed 2016-03-15 | -$37.11M derived: sum of 2 quarters · filed 2016-03-15 | -$54.32M derived: sum of 3 quarters · filed 2016-03-15 | -$70.01M 10-K · filed 2017-03-16 | ||||||
| 2014-09-30 | -$17.13M 10-K · filed 2016-03-15 | -$34.35M derived: sum of 2 quarters · filed 2016-03-15 | -$50.03M 10-Q · filed 2015-11-09 | -$63.94M derived: sum of 4 quarters · filed 2016-03-15 | ||||||
| 2014-06-30 | -$17.22M 10-K · filed 2016-03-15 | -$32.90M 10-Q · filed 2015-08-10 | -$46.80M derived: sum of 3 quarters · filed 2016-03-15 | -$60.24M derived: sum of 4 quarters · filed 2016-03-15 | ||||||
| 2014-03-31 | -$15.68M 10-K · filed 2016-03-15 | -$29.59M derived: sum of 2 quarters · filed 2016-03-15 | -$43.02M derived: sum of 3 quarters · filed 2016-03-15 | -$56.18M derived: sum of 4 quarters · filed 2016-03-15 | ||||||
| 2013-12-31 | -$13.90M 10-K · filed 2015-03-16 | -$27.34M derived: sum of 2 quarters · filed 2015-03-16 | -$40.50M derived: sum of 3 quarters · filed 2015-03-16 | -$50.52M 10-K · filed 2016-03-15 | ||||||
| 2013-09-30 | -$13.43M 10-K · filed 2015-03-16 | -$26.59M derived: sum of 2 quarters · filed 2015-03-16 | -$36.61M 10-Q · filed 2014-11-10 | -$44.15M derived: sum of 4 quarters · filed 2015-03-16 | ||||||
| 2013-06-30 | -$13.16M 10-K · filed 2015-03-16 | -$23.18M 10-Q · filed 2014-08-11 | -$30.71M derived: sum of 3 quarters · filed 2015-03-16 | -$43.75M derived: sum of 4 quarters · filed 2015-03-16 | ||||||
| 2013-03-31 | -$10.02M 10-K · filed 2015-03-16 | -$17.55M derived: sum of 2 quarters · filed 2015-03-16 | -$30.59M derived: sum of 3 quarters · filed 2015-03-16 | -$38.83M derived: sum of 4 quarters · filed 2015-03-16 | ||||||
| 2012-12-31 | -$7.53M 10-K · filed 2014-03-13 | -$20.57M derived: sum of 2 quarters · filed 2014-03-13 | -$28.81M derived: sum of 3 quarters · filed 2014-03-13 | -$36.88M 10-K · filed 2015-03-16 | ||||||
| 2012-09-30 | -$13.04M 10-K · filed 2014-03-13 | -$21.28M derived: sum of 2 quarters · filed 2014-03-13 | -$29.35M 10-Q · filed 2013-11-07 | -$39.20M derived: sum of 4 quarters · filed 2014-03-13 | ||||||
| 2012-06-30 | -$8.24M 10-K · filed 2014-03-13 | -$16.32M 10-Q · filed 2013-08-09 | -$26.16M derived: sum of 3 quarters · filed 2014-03-13 | -$32.33M derived: sum of 4 quarters · filed 2014-03-13 | ||||||
| 2012-03-31 | -$8.07M 10-K · filed 2014-03-13 | -$17.92M derived: sum of 2 quarters · filed 2014-03-13 | -$24.08M derived: sum of 3 quarters · filed 2014-03-13 | -$29.03M derived: sum of 4 quarters · filed 2014-03-13 | ||||||
| 2011-12-31 | -$9.85M 10-K · filed 2013-03-18 | -$16.01M derived: sum of 2 quarters · filed 2013-03-18 | -$20.96M derived: sum of 3 quarters · filed 2013-03-18 | -$27.41M 10-K · filed 2014-03-13 | ||||||
| 2011-09-30 | -$6.16M 10-K · filed 2013-03-18 | -$11.11M derived: sum of 2 quarters · filed 2013-03-18 | -$17.56M 10-Q · filed 2012-11-09 | -$26.12M derived: sum of 4 quarters · filed 2013-03-18 | -$170.64M 10-Q · filed 2011-11-08 | |||||
| 2011-06-30 | -$4.95M 10-K · filed 2013-03-18 | -$11.40M 10-Q · filed 2012-08-07 | -$19.96M derived: sum of 3 quarters · filed 2013-03-18 | -$27.45M derived: sum of 4 quarters · filed 2013-03-18 | -$164.48M 10-Q · filed 2011-08-09 | |||||
| 2011-03-31 | -$6.45M 10-K · filed 2013-03-18 | -$15.01M derived: sum of 2 quarters · filed 2013-03-18 | -$22.50M derived: sum of 3 quarters · filed 2013-03-18 | -$30.13M derived: sum of 4 quarters · filed 2013-03-18 | ||||||
| 2010-12-31 | -$8.56M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$16.05M derived: sum of 2 quarters · filed 2013-03-18 | -$23.68M derived: sum of 3 quarters · filed 2013-03-18 | -$30.11M 10-K · filed 2013-03-18 | ||||||
| 2010-09-30 | -$7.49M 10-Q · filed 2011-11-08 | -$15.12M derived: sum of 2 quarters · filed 2011-11-08 | -$21.55M 10-Q · filed 2011-11-08 | |||||||
| 2010-06-30 | -$7.63M 10-Q · filed 2011-08-09 | -$14.06M 10-Q · filed 2011-08-09 | ||||||||
| 2009-12-31 | -$20.76M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |